tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

DXCMDexcom

Health care · Medical Instruments · Nasdaq
Compare with peers → Embed
Cash returned and share count, year to Dec 31, 2025

Bought back $500.0M of its own shares, 3.1× what it paid in stock

XBRL, latest 10-K
Buybacks
$500.0M
cash paid for its own shares
Paid in stock to employees
$159.6M
stock-based compensation
Share count, 1 year
-1.7%
fewer shares: each share owns more
Share count, 3 years
-5.2%
diluted average shares
New shares against shares bought back

Dilution: new shares, stock pay and buybacks

S-3 and 424B, 3 years; 10-K

Shares offered

Since Nov 12, 2023: 1 shelf registration.

“Under this shelf registration process, we may, from time to time, sell an indeterminate amount of any combination of the securities described in this prospectus in one or more offerings.”

S-3ASR, Feb 18, 2025 ↗
Every offering filing →

Paid in stock

$159.6M

stock-based pay, year to Dec 31, 2025; shares sold for $28.1M in cash

Bought back

$500.0M

cash paid for its own shares, year to Dec 31, 2025: 3.1× the stock pay

Diluted shares: 405.50M in the year to Dec 31, 2025 2025 -1.7%2024 -3.0%2023 -0.5%2022 -0.3%

Change in the diluted weighted average share count from the fiscal year before, stock splits taken out. Bars use one scale for stock pay and buybacks. Prospectuses are read from their cover page; preliminary ones are left out. Cash & buybacks, year by year → · How

Where the cash went

Where the cash came from and where it went

10-K cash flow statement

FY2023 to FY2025, from the cash flow statements in the 10-Ks, added up.

Operating cash flowShares soldCapital spendingBuybacksAdded to cashOther, net Operating cash flow: $3.2B Operating cash flow $3.2B Shares sold: $82.9M Shares sold $82.9M Capital spending: $958.9M Capital spending $958.9M Buybacks: $1.9B Buybacks $1.9B Added to cash: $275.8M Added to cash $275.8M Other, net: $88.2M Other, net $88.2M

Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.

Year by year

Buybacks, dividends and share count

XBRL, each 10-K
Fiscal year toBuybacksDividendsStock payShares issued for cashDiluted shares
2025-12-31$500.0M -$159.6M $28.1M405.50M
2024-12-31$750.0M -$170.4M $28.2M412.70M
2023-12-31$688.7M -$150.8M $26.6M425.50M
2022-12-31$557.7M -$126.5M $22.5M427.50M
2021-12-31$0 -$113.4M $20.3M428.80M

From the XBRL of the 10-Ks (cash flow statement and diluted weighted average shares); each year as reported in the latest 10-K that includes it. Concepts: buybacks = PaymentsForRepurchaseOfCommonStock; sbc = ShareBasedCompensation; issuance = ProceedsFromIssuanceOfCommonStock; diluted_shares = WeightedAverageNumberOfDilutedSharesOutstanding.

Price paid

What it paid for each share it bought back

10-K, statement of shareholders' equity
Cheapest year
$65.40
fiscal year to Dec 31, 2025
Dearest year
$146.64
fiscal year to Dec 31, 2023
Average over these years
$86.09
$2.6B spent

What DXCM paid on average for each share it bought back, each fiscal year: dollars spent divided by shares bought, both from the 10-K.

Fiscal year toShares boughtSpentAverage price
2025-12-31 7.70M$503.6M $65.40
2024-12-31 10.40M$749.5M $72.07
2023-12-31 4.70M$689.2M $146.64
2022-12-31 6.60M$557.7M $84.50
2018-12-31 800K$100.0M $125.00

Shares and dollars from the statement of shareholders' equity (the cash flow line also counts shares withheld for taxes, so it is not used). Share counts filed before a stock split are put on today's count. A year where the 10-K does not tag both numbers is left out.

Next CEO pay →